Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/55814
Title: [COVID-19 pandemic. What have we learned?]
Other Titles: Pandemia COVID-19. ¿Qué hemos aprendido en este tiempo?
Authors: 
Keywords: 
Issue Date: 23-Sep-2021
Citation: An Pediatr (Barc).2021;(95)5:382.e1-382.e8
Abstract: Since the COVID-19 pandemic was declared in March 2020, we have learned a lot about the SARS-CoV-2 coronavirus, and its role in pediatric pathology.Children are infected in a rate quite similar to adults, although in most cases they suffer mild or asymptomatic symptoms. Around 1% of those infected require hospitalization, less than 0.02% require intensive care, and mortality is very low and generally in children with comorbidities. The most common clinical diagnoses are upper or lower respiratory infections, gastrointestinal infection and, more seriously, multisystemic inflammatory syndrome (MIS-C). Most episodes do not require treatment, except for MIS-C. Remdesivir has been widely used as a compassionate treatment and its role has yet to be defined.The newborn can become infected, although vertical transmission is very low (
PMID: 34580593
URI: https://hdl.handle.net/20.500.12530/55814
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > FIIB H. U. Infanta Sofía y H. U. Henares > Artículos

Files in This Item:
File SizeFormat 
PMC8457926.pdf1.08 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons